Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urban Population | 3 | 2025 | 195 | 0.460 |
Why?
|
| Vagina | 2 | 2025 | 83 | 0.400 |
Why?
|
| Intellectual Disability | 1 | 2025 | 168 | 0.390 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 168 | 0.360 |
Why?
|
| Kidney Transplantation | 2 | 2024 | 319 | 0.340 |
Why?
|
| Cervix Uteri | 2 | 2025 | 60 | 0.320 |
Why?
|
| Time-to-Treatment | 3 | 2024 | 112 | 0.300 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 676 | 0.260 |
Why?
|
| Vaginosis, Bacterial | 2 | 2025 | 15 | 0.240 |
Why?
|
| Microbiota | 2 | 2025 | 129 | 0.230 |
Why?
|
| Chlamydia trachomatis | 1 | 2025 | 55 | 0.220 |
Why?
|
| Metabolic Diseases | 1 | 2025 | 58 | 0.220 |
Why?
|
| Chlamydia Infections | 1 | 2025 | 75 | 0.220 |
Why?
|
| Laryngeal Neoplasms | 1 | 2024 | 51 | 0.220 |
Why?
|
| Cost of Illness | 1 | 2025 | 162 | 0.210 |
Why?
|
| Trichomonas Vaginitis | 1 | 2023 | 7 | 0.210 |
Why?
|
| Trichomonas vaginalis | 1 | 2023 | 9 | 0.210 |
Why?
|
| Food | 1 | 2024 | 77 | 0.200 |
Why?
|
| Acidosis | 1 | 2023 | 27 | 0.200 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2023 | 37 | 0.200 |
Why?
|
| Poverty | 1 | 2025 | 298 | 0.190 |
Why?
|
| Spouse Abuse | 1 | 2023 | 44 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 346 | 0.190 |
Why?
|
| Health Literacy | 1 | 2023 | 85 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 259 | 0.190 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 141 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 132 | 0.180 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 168 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 149 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 133 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 98 | 0.180 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 254 | 0.180 |
Why?
|
| Case-Control Studies | 3 | 2025 | 1119 | 0.170 |
Why?
|
| Child, Preschool | 4 | 2025 | 1994 | 0.170 |
Why?
|
| Female | 15 | 2025 | 32930 | 0.170 |
Why?
|
| Hypersensitivity | 1 | 2021 | 64 | 0.170 |
Why?
|
| Humans | 21 | 2025 | 63532 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 129 | 0.160 |
Why?
|
| India | 2 | 2025 | 159 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 343 | 0.160 |
Why?
|
| Adolescent | 7 | 2025 | 6251 | 0.150 |
Why?
|
| Hypertension | 1 | 2024 | 587 | 0.150 |
Why?
|
| Child | 5 | 2025 | 4530 | 0.150 |
Why?
|
| Telemedicine | 1 | 2023 | 327 | 0.140 |
Why?
|
| Depression | 1 | 2025 | 901 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 90 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 838 | 0.130 |
Why?
|
| Cervix Mucus | 1 | 2016 | 1 | 0.130 |
Why?
|
| Mouth | 1 | 2016 | 33 | 0.130 |
Why?
|
| Risk Factors | 5 | 2025 | 5361 | 0.130 |
Why?
|
| Neoplasms | 2 | 2024 | 1364 | 0.130 |
Why?
|
| Anal Canal | 1 | 2016 | 37 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 919 | 0.120 |
Why?
|
| Asthma | 1 | 2021 | 459 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2018 | 360 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2579 | 0.120 |
Why?
|
| Prevalence | 3 | 2025 | 1384 | 0.120 |
Why?
|
| Male | 9 | 2025 | 29937 | 0.120 |
Why?
|
| Heart Failure | 1 | 2023 | 914 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 415 | 0.110 |
Why?
|
| Pakistan | 2 | 2025 | 17 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1198 | 0.110 |
Why?
|
| Liver | 1 | 2018 | 855 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2024 | 6675 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2012 | 10 | 0.100 |
Why?
|
| Metagenome | 1 | 2012 | 18 | 0.100 |
Why?
|
| Young Adult | 4 | 2025 | 4701 | 0.090 |
Why?
|
| Aged | 5 | 2025 | 14479 | 0.090 |
Why?
|
| Infant | 1 | 2025 | 1648 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2025 | 88 | 0.080 |
Why?
|
| Middle Aged | 5 | 2025 | 17653 | 0.080 |
Why?
|
| Adult | 5 | 2025 | 16849 | 0.070 |
Why?
|
| Biomarkers | 2 | 2024 | 1409 | 0.060 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2025 | 25 | 0.060 |
Why?
|
| Cystatin C | 1 | 2024 | 9 | 0.050 |
Why?
|
| Chemoradiotherapy | 1 | 2024 | 67 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2024 | 61 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2023 | 8 | 0.050 |
Why?
|
| Creatinine | 1 | 2024 | 134 | 0.050 |
Why?
|
| Alkalies | 1 | 2023 | 4 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 16 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 113 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2023 | 28 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 57 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2023 | 35 | 0.050 |
Why?
|
| Physical Abuse | 1 | 2023 | 4 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 35 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2024 | 584 | 0.050 |
Why?
|
| Community Health Services | 1 | 2024 | 128 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 103 | 0.050 |
Why?
|
| Molecular Medicine | 1 | 2022 | 2 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2023 | 250 | 0.050 |
Why?
|
| Survival Rate | 1 | 2024 | 852 | 0.050 |
Why?
|
| Metagenomics | 1 | 2022 | 28 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 517 | 0.050 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 19 | 0.050 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2021 | 6 | 0.040 |
Why?
|
| Desensitization, Immunologic | 1 | 2021 | 12 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 22 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 53 | 0.040 |
Why?
|
| New York | 1 | 2021 | 145 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 265 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1256 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 394 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 444 | 0.040 |
Why?
|
| Internet | 1 | 2023 | 469 | 0.040 |
Why?
|
| Bacteria | 1 | 2022 | 306 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 39 | 0.040 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 26 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2024 | 694 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2574 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 935 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 444 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 110 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 485 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2682 | 0.030 |
Why?
|
| Diet | 1 | 2018 | 527 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 356 | 0.030 |
Why?
|
| Quality of Life | 1 | 2021 | 1230 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1553 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 265 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 313 | 0.020 |
Why?
|